News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
747,323 Results
Type
Article (64405)
Company Profile (476)
Press Release (682430)
Multimedia
Podcasts (168)
Webinars (23)
Section
Business (195104)
Career Advice (3426)
Deals (35289)
Drug Delivery (144)
Drug Development (85575)
Employer Resources (187)
FDA (17634)
Job Trends (15269)
News (344330)
Policy (35980)
Tag
Academia (2954)
Academic (1)
Accelerated approval (31)
Adcomms (36)
Allergies (138)
Alliances (50582)
ALS (175)
Alzheimer's disease (1763)
Antibody-drug conjugate (ADC) (318)
Approvals (17786)
Artificial intelligence (536)
Autoimmune disease (142)
Automation (34)
Bankruptcy (371)
Best Places to Work (11849)
BIOSECURE Act (23)
Biosimilars (197)
Biotechnology (326)
Bladder cancer (155)
Brain cancer (62)
Breast cancer (628)
Cancer (4785)
Cardiovascular disease (420)
Career advice (2919)
Career pathing (39)
CAR-T (296)
CDC (59)
Celiac Disease (1)
Cell therapy (792)
Cervical cancer (37)
Clinical research (72172)
Collaboration (1651)
Company closure (5)
Compensation (1105)
Complete response letters (68)
COVID-19 (2957)
CRISPR (94)
C-suite (776)
Cystic fibrosis (149)
Data (6009)
Decentralized trials (2)
Denatured (56)
Depression (135)
Diabetes (507)
Diagnostics (6850)
Digital health (40)
Diversity (10)
Diversity, equity & inclusion (47)
Drug discovery (267)
Drug pricing (211)
Drug shortages (36)
Duchenne muscular dystrophy (228)
Earnings (78440)
Editorial (60)
Employer branding (22)
Employer resources (162)
Events (121916)
Executive appointments (984)
FDA (20597)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (22)
Funding (1450)
Gene editing (205)
Generative AI (46)
Gene therapy (638)
GLP-1 (1088)
Government (5223)
Grass and pollen (8)
Guidances (376)
Healthcare (19891)
HIV (53)
Huntington's disease (46)
IgA nephropathy (85)
Immunology and inflammation (280)
Immuno-oncology (45)
Indications (80)
Infectious disease (3231)
Inflammatory bowel disease (198)
Inflation Reduction Act (16)
Influenza (115)
Intellectual property (228)
Interviews (665)
IPO (16734)
IRA (60)
Job creations (3813)
Job search strategy (2368)
Kidney cancer (16)
Labor market (82)
Layoffs (636)
Leadership (38)
Legal (8574)
Liver cancer (97)
Longevity (13)
Lung cancer (657)
Lymphoma (367)
Machine learning (38)
Management (63)
Manufacturing (760)
MASH (169)
Medical device (14151)
Medtech (14192)
Mergers & acquisitions (19582)
Metabolic disorders (1322)
Multiple sclerosis (155)
NASH (23)
Neurodegenerative disease (329)
Neuropsychiatric disorders (89)
Neuroscience (3001)
NextGen: Class of 2026 (7054)
Non-profit (4855)
Now hiring (50)
Obesity (641)
Opinion (325)
Ovarian cancer (158)
Pain (193)
Pancreatic cancer (213)
Parkinson's disease (281)
Partnered (33)
Patents (479)
Patient recruitment (440)
Peanut (59)
People (58674)
Pharmaceutical (87)
Pharmacy benefit managers (31)
Phase I (22418)
Phase II (31569)
Phase III (23873)
Pipeline (4283)
Policy (323)
Postmarket research (2895)
Preclinical (9732)
Press Release (69)
Prostate cancer (234)
Psychedelics (53)
Radiopharmaceuticals (292)
Rare diseases (831)
Real estate (6160)
Recruiting (75)
Regulatory (26535)
Reports (50)
Research institute (2675)
Resumes & cover letters (545)
Rett syndrome (25)
RNA editing (16)
RSV (81)
Schizophrenia (155)
Series A (242)
Series B (181)
Service/supplier (12)
Sickle cell disease (102)
Special edition (27)
Spinal muscular atrophy (167)
Sponsored (47)
Startups (3743)
State (2)
Stomach cancer (20)
Supply chain (108)
Tariffs (97)
The Weekly (111)
Vaccines (1106)
Venture capital (85)
Weight loss (441)
Women's health (75)
Worklife (21)
Date
Today (140)
Last 7 days (535)
Last 30 days (1924)
Last 365 days (32259)
2026 (536)
2025 (32169)
2024 (37007)
2023 (41641)
2022 (52833)
2021 (57445)
2020 (55782)
2019 (48568)
2018 (36860)
2017 (34903)
2016 (34814)
2015 (39967)
2014 (33008)
2013 (27889)
2012 (29738)
2011 (29995)
2010 (28001)
Location
Africa (1037)
Alabama (85)
Alaska (7)
Arizona (289)
Arkansas (14)
Asia (44387)
Australia (7700)
California (10867)
Canada (3147)
China (1094)
Colorado (450)
Connecticut (479)
Delaware (323)
Europe (102736)
Florida (1610)
Georgia (344)
Hawaii (3)
Idaho (64)
Illinois (865)
India (59)
Indiana (487)
Iowa (23)
Japan (400)
Kansas (126)
Kentucky (41)
Louisiana (27)
Maine (81)
Maryland (1392)
Massachusetts (8094)
Michigan (321)
Minnesota (611)
Mississippi (5)
Missouri (127)
Montana (31)
Nebraska (23)
Nevada (112)
New Hampshire (81)
New Jersey (2979)
New Mexico (32)
New York (2921)
North Carolina (1501)
North Dakota (10)
Northern California (5213)
Ohio (327)
Oklahoma (22)
Oregon (42)
Pennsylvania (2193)
Puerto Rico (19)
Rhode Island (44)
South America (1399)
South Carolina (60)
South Dakota (1)
Southern California (4199)
Tennessee (163)
Texas (1696)
United States (39321)
Utah (323)
Vermont (1)
Virginia (257)
Washington D.C. (82)
Washington State (910)
West Virginia (4)
Wisconsin (114)
Wyoming (1)
747,323 Results for "the parkinson s institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Parkinson’s disease
AC Immune’s Parkinson’s Immunotherapy Appears to Slow Disease Progression
In a first for the Parkinson’s field, AC Immune’s immunotherapy has stabilized key biomarkers that suggest an effect on the disease’s course.
December 11, 2025
·
1 min read
·
Annalee Armstrong
Deals
Arrowhead Nabs up to $2B Novartis Commitment for siRNA Parkinson’s Program
Novartis is licensing ARO-SNCA, a preclinical siRNA therapy for synucleinopathies, a group of neurodegenerative disorders including Parkinson’s disease.
September 2, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Hope Biosciences Research Foundation Reports Promising Phase II Trial Results for Stem Cell Therapy in Parkinson’s Disease
December 23, 2025
·
3 min read
Press Releases
Kenai Therapeutics Receives $8M Grant from California Institute for Regenerative Medicine (CIRM) to Advance RNDP-001 for Treatment of Idiopathic Parkinson’s Disease
January 5, 2026
·
4 min read
Press Releases
SynuSight Biotech, ABLi Therapeutics and XingImaging Announce Strategic Collaboration to Implement Alpha-Synuclein PET Imaging into Clinical Trials Evaluating Risvodetinib as a Disease-modifying Therapy for Parkinson’s Disease
January 5, 2026
·
6 min read
Funding
Aspen’s $115M Series C Opens Doors to Late-Stage Development for Parkinson’s Program
Aspen is now also considering the possibility of an initial public offering next year in an effort to bring its cell therapy to the market.
November 20, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Vertero Initiates Phase 1 Study of VT-5006, A Selective Small Molecule Therapy for Parkinson’s Disease
November 24, 2025
·
3 min read
Press Releases
Gain Therapeutics Announces Positive Results in Key Exploratory Endpoint from its Phase 1b Clinical Study of GT-02287 in People with Parkinson’s Disease
December 18, 2025
·
8 min read
Press Releases
Cerevance to Highlight Potential of Solengepras in Parkinson’s Disease at the 2025 Parkinson Study Group Annual Meeting
November 24, 2025
·
2 min read
Press Releases
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
October 9, 2025
·
8 min read
1 of 74,733
Next
